首页> 外文期刊>Annals of Clinical Microbiology and Antimicrobials >Acquisition of rifabutin resistance by a rifampicin resistant mutant of Mycobacterium tuberculosis involves an unusual spectrum of mutations and elevated frequency
【24h】

Acquisition of rifabutin resistance by a rifampicin resistant mutant of Mycobacterium tuberculosis involves an unusual spectrum of mutations and elevated frequency

机译:结核分枝杆菌的耐利福平突变体获得对利福布汀的耐药性涉及异常范围的突变和频率升高

获取原文
       

摘要

Background Mutations in a small region of the rpoB gene are responsible for most rifamycin resistance in Mycobacterium tuberculosis. In this study we have sequentially generated resistant strains to first rifampicin and then rifabutin. Portions of the rpoB gene were sequenced from 131 randomly selected mutants. Second round selection resulted in a changed frequency of specific mutations. Methods Mycobacterium tuberculosis (strain Mtb72) rifamycin resistant mutants were selected in vitro with either rifampicin or rifabutin. One mutant R190 (rpoB S522L) selected with rifampicin had a rifampicin MIC of 32 μg/ml but remained sensitive to rifabutin (MIC Results All 105 first round resistant mutants derived from the parent strain (Mtb72) screened acquired mutations within the 81 bp rpoB hotspot. When the rifampicin resistant but rifabutin sensitive S522L mutant was subjected to a second round of selection, single additional rpoB mutations were identified in 24 (92%) of 26 second round mutants studied, but 14 (54%) of these strains contained mutations outside the 81 bp hotspot (codons 144, 146, 148, 505). Additionally, spontaneous rifabutin resistant mutants were produced at >10 times the frequency by the S522L mutant than the parent strain. Conclusion First round selection of mutation S522L with rifampicin increased the frequency and changed the spectrum of mutations identified after selection with rifabutin.
机译:背景在结核分枝杆菌中,rpoB基因小区域的突变是导致大多数利福霉素耐药的原因。在这项研究中,我们先后产生了对利福平然后对利福布汀的抗性菌株。 rpoB基因的一部分从131个随机选择的突变体中测序。第二轮选择导致特定突变的频率改变。方法采用利福平或利福布汀体外筛选结核分枝杆菌(Mtb72菌株)耐利福霉素突变体。用利福平选择的一个突变体R190(rpoB S522L)的利福平MIC为32μg/ ml,但对利福布汀仍然敏感(MIC结果)来源于亲本菌株(Mtb72)的所有105个第一轮耐药突变体均在81 bp rpoB热点内筛选了获得性突变当对利福平耐药但对利福布丁敏感的S522L突变体进行第二轮选择时,在研究的26个第二轮突变体中有24个(92%)鉴定出单个额外的rpoB突变,但是其中14个(54%)菌株含有外部突变结论:81 bp的热点(密码子144、146、148、505)另外,自发的对利福布汀抗性的突变体产生的S522L突变体的频率是其亲本菌株的> 10倍。并更改了使用利福布汀选择后鉴定出的突变谱。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号